American Vanguard Corporation (AVD) Stock Price, News & Analysis

American Vanguard Corporation (NYSE: AVD) is a diversified specialty and agriculture products company in the pesticide and agricultural chemical manufacturing industry. According to the company’s public disclosures, it develops and markets products for crop protection and management, turf and ornamentals management, and public and animal health. The business operates within the broader manufacturing sector and focuses on chemical solutions that support agricultural productivity and environmental management.

American Vanguard states that, over a period of more than 20 years, it has expanded through product and business acquisitions and now holds more than 1,000 product registrations worldwide. In its descriptions, the company notes that it has expanded its operations into numerous countries and maintains registrations in dozens of nations. These registrations reflect a broad portfolio of specialty and agricultural products that are subject to regulatory oversight in multiple jurisdictions.

In addition to developing and marketing crop protection and management products, American Vanguard reports activity in turf and ornamental management. This includes products intended for managed green spaces and ornamental plant care. The company also highlights its participation in public and animal health markets, indicating that some of its products are used in settings beyond row-crop agriculture, such as commercial pest control and other non-crop applications.

American Vanguard’s public communications describe it as a diversified specialty and agricultural products company that also manufactures certain solutions. In multiple earnings releases, the company characterizes itself as developing, manufacturing, and marketing solutions for crop protection and nutrition, turf and ornamental management, and commercial pest control. This combination of development, manufacturing, and marketing activities positions the company as an integrated participant in the agricultural chemical value chain.

The company’s securities filings identify its common stock, with a par value of $0.10 per share, as trading on the New York Stock Exchange under the symbol AVD. American Vanguard’s principal operating subsidiary, AMVAC Chemical Corporation, is party to a Third Amended and Restated Loan and Security Agreement with a group of commercial lenders led by BMO Bank, N.A., and the parent company and certain affiliates act as guarantors and/or borrowers under that agreement. Amendments to this credit facility, including changes to maturity, borrowing capacity and financial covenants, are disclosed in the company’s Form 8-K filings.

In its financial reporting, American Vanguard discloses sales across U.S. crop, U.S. non-crop, and international categories. U.S. crop sales relate to agricultural uses within the United States, while U.S. non-crop sales reflect specialty and other non-row-crop applications, and international sales represent activity outside the U.S. These categories appear in the company’s analysis of sales tables in its quarterly results. The company also reports on gross profit, operating expenses, research, product development and regulatory costs, and various transformation and restructuring-related items.

American Vanguard uses non-GAAP measures such as Adjusted EBITDA in its communications and SEC filings. The company defines EBITDA as net income (or net income attributable to the company) adjusted for non-controlling interests, depreciation and amortization, provision for income taxes and interest expense. Adjusted EBITDA is defined as EBITDA further adjusted for items that management believes are not reflective of underlying operations, including non-recurring expenses and certain gains. The company states that it uses Adjusted EBITDA to assess operating results and that this measure is aligned with the metric used in its credit facility.

From time to time, American Vanguard discusses business transformation and improvement efforts in its earnings releases. These communications reference initiatives to simplify the business, prioritize key activities and deliver on operational goals. The company has disclosed transformation-related expenses, product liability charges associated with a contaminated product formulated by a third party, and asset impairment charges, all of which are detailed in its financial statements and reconciliations to non-GAAP measures.

American Vanguard has also reported on its capital structure and liquidity, including total debt outstanding, inventory levels, and net working capital. Management commentary in earnings releases has emphasized efforts to reduce inventory, manage working capital, and allocate free cash flow toward debt reduction, as well as to improve manufacturing efficiency and procurement processes. These efforts are presented as part of a broader plan to strengthen the balance sheet and support the company’s long-term objectives.

In a press release dated January 14, 2026, American Vanguard announced a decision to relocate its corporate headquarters from Newport Beach, California to Discovery Park in Irvine, California. The company described the new office environment as intended to encourage collaboration and teamwork and indicated that it expects the move to be completed by the end of the second quarter of 2026. The same announcement also discussed changes in the executive management team and reiterated management’s focus on simplifying, prioritizing, and delivering within the organization.

American Vanguard holds annual meetings of stockholders, where shareholders vote on the election of directors, the ratification of the independent registered public accounting firm, and advisory approvals of executive compensation policies. Voting results, including director election outcomes and vote tallies for other proposals, are reported in the company’s Form 8-K filings and related press releases.

Business focus and product areas

According to repeated company descriptions in its news releases, American Vanguard’s primary business focus is on:

• Crop protection and management – products used in agricultural settings to support crop health and yield.
• Crop nutrition – solutions that the company associates with supporting crop growth and productivity.
• Turf and ornamentals management – products for turfgrass and ornamental plants in managed environments.
• Commercial pest control – solutions used in non-residential pest management.
• Public and animal health – products aimed at protecting public health and animal health.

In addition, earlier descriptions indicate that American Vanguard manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, marketed in liquid, powder, and granular forms.

Geographic reach and registrations

American Vanguard has publicly stated that, through acquisitions and expansion, it has more than 1,000 product registrations worldwide. In one description, the company notes that it has expanded its operations into 21 countries and holds more than 1,000 product registrations in 56 nations. These registrations reflect the regulatory approvals required to sell and distribute its specialty and agricultural products in multiple markets.

Stock and regulatory reporting

American Vanguard’s common stock trades on the New York Stock Exchange under the ticker symbol AVD. As a public company, it files periodic and current reports with the U.S. Securities and Exchange Commission, including Forms 10-K, 10-Q, and 8-K. These filings provide detailed information on the company’s financial condition, results of operations, risk factors, corporate governance, and material events such as amendments to credit agreements, earnings announcements, and stockholder meeting results.

Risk and transformation disclosures

In its public communications, American Vanguard has described a challenging environment for suppliers to the global agricultural sector, including economic uncertainty and customer efforts to manage working capital. The company has reported declines in net sales in some periods compared to prior years and has discussed cost reduction initiatives, business transformation efforts, and steps to improve margins and operating leverage. It has also disclosed non-recurring cash and non-cash charges associated with repositioning the business, including asset impairments and product liability-related charges.